Individual Shareholder Nam Files Injunction to Halt Enzychem Lifesciences EGM as Governance Dispute Intensifies
Shareholder Nam has filed a provisional injunction with the Cheongju District Court Jecheon Branch to prohibit Enzychem Lifesciences from holding its extraordinary general meeting scheduled for July 23, 2026.
The EGM agenda includes the appointment of new directors and auditors as well as amendments to the articles of incorporation.
The company states it will respond through lawful procedures. This litigation heightens governance uncertainty and may escalate the management control dispute, negatively impacting shareholder value.
[AI Summary]The legal escalation of a management dispute increases governance risk and near-term stock price volatility. Investors should monitor developments closely as the outcome may influence board composition and strategic direction.
KOSDAQ Filing Information
Filing of Lawsuit, etc. (Management Dispute Lawsuit) (Provisional Disposition to Prohibit Extraordinary General Meeting of Shareholders)